Nonalcoholic Fatty Liver Disease (NAFLD) Database 3

Summary

The NAFLD Database 3 will enroll approximately 1500 adult patients and 750 pediatric patients suspected or known to have NAFLD or NASH-related cirrhosis. To elucidate, through the cooperative effort of a multidisciplinary and multicenter group of collaborators, the etiology, natural history, diagnosis, treatment, and prevention of NAFLD, and in particular its more severe form of NASH and its complications.

Conditions

• Liver Diseases

Sponsors & Collaborators

• National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

  collaborator NIH

• Baylor College of Medicine

  collaborator OTHER

• Case Western Reserve University

  collaborator OTHER

• Duke University

  collaborator OTHER

• Ann & Robert H Lurie Children's Hospital of Chicago

  collaborator OTHER

• Indiana University

  collaborator OTHER

• Liver Institute Northwest

  collaborator UNKNOWN

• Seattle Children's Hospital

  collaborator OTHER

• St. Louis University

  collaborator OTHER

• University of California, San Diego

  collaborator OTHER

• University of California, San Francisco

  collaborator OTHER

• University of Southern California

  collaborator OTHER

• Virginia Commonwealth University

  collaborator OTHER

• Emory University

  collaborator OTHER

• Children's Hospital Medical Center, Cincinnati

  collaborator OTHER

• Johns Hopkins Bloomberg School of Public Health

  lead OTHER

Principal Investigators

• Arun Sanyal, MD · Virginia Commonwealth University Medical Center

• Brent Tetri, MD · St Louis University Hospital

Eligibility

Min Age

2 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2020-11-13

Primary Completion

2025-07-09

Completion

2025-07-09

Countries

• United States

Study Locations